We have invited URAC-accredited clients and other stakeholders to review the proposed measures and share their comments and recommendations during our public comment period, which began Tuesday, July 18, 2017 and will close on Thursday, August 31, 2017.

URAC regularly reviews and revises its measures to consistently align with current market needs, government regulations, and industry trends. By doing so, URAC demonstrates commitment to measuring and reporting on performance to offer greater transarency and increase consumer empowerment. 

Performance measure selection and development is done collaboratively with multiple stakeholders working through a multi-stage process that includes this public comment phase. Comments related to the programs in general, on the addition of measures to the Health Plan, Pharmacy Quality Management, or Telehealth Accreditation programs, on any of the individual measures or their specifications, and/or on the proposed classification of measures as mandatory or exploratory are welcomed.

For more information, please contact URAC’s Quality, Research, and Measurement team at researchmeasurement@urac.org.